Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for Cellectis S.A. (CLLS)

« Back to company index

CLLS Chatter Timeline

Stock Ticker for CLLS

Most Active Tweeters for CLLS

UserTweets
@AmericanBanking 3
@TranscriptDaily 3
@portefeuillefun 3
@EnterpriseLeade 2
@theflynews 2

Recent Tweets for CLLS

ConsumerFeed @ConsumerFeed
Cellectis $CLLS Rating Increased to Buy at BidaskClub https://t.co/W1I99ZqJMG
December 7th 2019, 8:12am
dailypoliticaln @dailypoliticaln
Cellectis $CLLS Upgraded at BidaskClub https://t.co/4rrSUa8gzp
December 6th 2019, 10:12pm
TickerReport @TickerReport
Cellectis $CLLS Upgraded to Buy by BidaskClub https://t.co/DXdPmPUyTQ
December 6th 2019, 10:12pm
YMuer @YMuer
Cellectis:  Monthly Information on Share Capital and Company Voting Rights https://t.co/joxEYp4jtS $CLLS
December 6th 2019, 6:12am
AmericanBanking @AmericanBanking
Cellectis SA $CLLS Given Average Recommendation of “Buy” by Brokerages https://t.co/PSKBgN9ny8 #stocks
December 6th 2019, 2:12am
dakotafinancial @dakotafinancial
Cellectis SA $CLLS Given Average Recommendation of “Buy” by Brokerages https://t.co/82aAX1Zs5I
December 6th 2019, 2:12am
TradeFlags @TradeFlags
TD SELL $CLLS at 14.56, Supp 13.08 Resis 14.58 R11 HiLo 43% T1Y 40 buy 1.6 fwdPE -6.1 DIV N/A #Cellectis #stocks… https://t.co/5MVGhEmmxA
December 5th 2019, 8:12pm
newsfilterio @newsfilterio
Cellectis: Monthly Information on Share Capital and Company Voting Rights $CLLS https://t.co/d46FkNlWdf
December 5th 2019, 6:12pm
EnterpriseLeade @EnterpriseLeade
Contrasting Proteon Therapeutics $PRTO and Cellectis $CLLS https://t.co/CiHbTig1gL
December 5th 2019, 8:12am
TranscriptDaily @TranscriptDaily
Contrasting Cellectis $CLLS and Proteon Therapeutics $PRTO https://t.co/VDetZOSKwY
December 5th 2019, 8:12am
AmericanBanking @AmericanBanking
Contrasting Cellectis $CLLS and Proteon Therapeutics $PRTO https://t.co/Bruj4KN3Vy #stocks
December 5th 2019, 8:12am
EnterpriseLeade @EnterpriseLeade
Cellectis $CLLS Upgraded to “Buy” by BidaskClub https://t.co/SUFJNn4nnQ
December 5th 2019, 4:12am
TranscriptDaily @TranscriptDaily
Cellectis $CLLS Upgraded to “Buy” by BidaskClub https://t.co/XOprw08nj1
December 5th 2019, 4:12am
TheMarketsDaily @TheMarketsDaily
Head-To-Head Survey: argenx $ARGX & Cellectis $CLLS https://t.co/amBsva0dmO
December 5th 2019, 3:12am
MiniZin2 @MiniZin2
@npsullia $clxt ownership by $clls is 69%
December 4th 2019, 8:12pm
npsullia @npsullia
$CLXT it’s 60% owned by $CLLS if you aren’t aware
December 4th 2019, 3:12pm
susanfoofoo @susanfoofoo
RT @theflynews: Meet Cellectis: A Fly exclusive interview with CEO Andre Choulika $CLLS $ALLO https://t.co/ZxxM6jmI23
December 3rd 2019, 2:12pm
gregorypozo @gregorypozo
RT @theflynews: Cellectis CEO calls notion company 'gave away' pipeline 'totally wrong' $CLLS https://t.co/x9iKWWGp0B
December 3rd 2019, 2:12pm
theflynews @theflynews
Meet Cellectis: A Fly exclusive interview with CEO Andre Choulika $CLLS $ALLO https://t.co/ZxxM6jmI23
December 3rd 2019, 1:12pm
theflynews @theflynews
Cellectis CEO calls notion company 'gave away' pipeline 'totally wrong' $CLLS https://t.co/x9iKWWGp0B
December 3rd 2019, 1:12pm
portefeuillefun @portefeuillefun
$CLLS. https://t.co/9Ysc4ezG22
December 2nd 2019, 5:12pm
biotechradar_eu @biotechradar_eu
1st Patient Dosed with Cellectis $ALCLS $CLLS’ Allogeneic UCART22 in Relapsed/Refractory B-cell Acute Lymphoblastic… https://t.co/413RYPEShJ
December 2nd 2019, 5:12pm
SHarnest @SHarnest
$CLLS https://t.co/ZFWdeEJqPC
December 2nd 2019, 4:12pm
otcdynamics @otcdynamics
$CLLS 1st Patient Dosed with Cellectis’ Allogeneic UCART22 in Relapsed/Refractory B-cell Acute Lymphoblastic L https://t.co/Et0CC0386D
December 2nd 2019, 4:12pm
portefeuillefun @portefeuillefun
Sold 1k $CLLS at $14.55, now 9k #vssporte shares.
December 2nd 2019, 12:12pm
dispatchtribune @dispatchtribune
Head-To-Head Comparison: argenx $ARGX and Cellectis $CLLS https://t.co/ukyhqUPKtg
November 30th 2019, 10:11am
OlympiaReport @OlympiaReport
Cellectis $CLLS and argenx $ARGX Head to Head Comparison https://t.co/dcqSKnc9Uw
November 30th 2019, 10:11am
AmericanBanking @AmericanBanking
Head-To-Head Comparison: argenx $ARGX and Cellectis $CLLS https://t.co/B57EHCwc1Q #stocks
November 30th 2019, 10:11am
AnthemTrading @AnthemTrading
$CLLS (14.17) Possible ASH play?
November 27th 2019, 2:11pm
gcassidy718 @gcassidy718
$CLLS here we go!! 3.45 % change recently https://t.co/Hry9HpLNxp
November 25th 2019, 8:11pm
portefeuillefun @portefeuillefun
Sold 2k $CLLS at $14.06, now 10k #vssporte shares.
November 25th 2019, 1:11pm
TranscriptDaily @TranscriptDaily
Zacks: Analysts Expect Cellectis SA $CLLS Will Announce Quarterly Sales of $3.87 Million https://t.co/dMuiMvJM2J
November 24th 2019, 8:11pm
stocknewstimes @stocknewstimes
Cellectis SA $CLLS Expected to Post Quarterly Sales of $3.87 Million https://t.co/sr2knk8xhp
November 24th 2019, 8:11pm
ConsumerFeed @ConsumerFeed
Zacks: Brokerages Expect Cellectis SA $CLLS to Announce -$0.84 Earnings Per Share https://t.co/puqF0q2G1r
November 22nd 2019, 6:11pm
TickerReport @TickerReport
Analysts Anticipate Cellectis SA $CLLS Will Announce Quarterly Sales of $3.87 Million https://t.co/Veu3nrCfTa
November 22nd 2019, 6:11pm
WatchlistN @WatchlistN
Zacks: Analysts Expect Cellectis SA $CLLS to Post -$0.84 EPS https://t.co/xhqOZTg5Pa
November 22nd 2019, 6:11pm
dailypoliticaln @dailypoliticaln
$3.87 Million in Sales Expected for Cellectis SA $CLLS This Quarter https://t.co/2WfjkDrRXE
November 22nd 2019, 6:11pm
PiescheLab @PiescheLab
Improving CAR technology: Cellectis Details Proof-of-Concept for “Smart” CAR T-Cells https://t.co/CkkZb52Jhl $clls #cancer #immunotherapy
November 22nd 2019, 1:11pm
Gambiste1 @Gambiste1
RT @1stOncology: #Cellectis Wins Patent Challenge in Europe for a Method Using #CRISPRCas9 for Gene Editing in #TCells $CLLS https://t.co/9…
November 22nd 2019, 7:11am
1stOncology @1stOncology
#Cellectis Wins Patent Challenge in Europe for a Method Using #CRISPRCas9 for Gene Editing in #TCells $CLLS https://t.co/9cQaCO36sv
November 22nd 2019, 5:11am
Gambiste1 @Gambiste1
RT @portefeuillefun: Bought 4.5k $CLLS at €12.02, now 12k #vssporte shares.
November 22nd 2019, 5:11am
portefeuillefun @portefeuillefun
Bought 4.5k $CLLS at €12.02, now 12k #vssporte shares.
November 22nd 2019, 4:11am
celltrialsdata @celltrialsdata
#RT @cells_nnm: RT @JacobPlieth: Some pretty significant manufacturing investments at $CLLS #Jefferies19 https://t.co/v0oGsBFbyH
November 21st 2019, 12:11pm
BiotechAnalysst @BiotechAnalysst
RT @_B_I_O_T_E_C_H_: Wenn $CLLS patent is upheld for CRISPR in oncology and $SGMO patent was granted first for CRISPR in BCL11A ? there mi…
November 21st 2019, 12:11pm
cells_nnm @cells_nnm
RT @JacobPlieth: Some pretty significant manufacturing investments at $CLLS #Jefferies19 https://t.co/U1SEUBOVQt
November 21st 2019, 12:11pm
_B_I_O_T_E_C_H_ @_B_I_O_T_E_C_H_
Wenn $CLLS patent is upheld for CRISPR in oncology and $SGMO patent was granted first for CRISPR in BCL11A ? there… https://t.co/0n4PL9XBJk
November 21st 2019, 9:11am
_B_I_O_T_E_C_H_ @_B_I_O_T_E_C_H_
$CLLS Cellectis Wins Patent Challenge in Europe for a Method Using CRISPR-Cas9 for Gene Editing in T-Cells… https://t.co/jEKJYDbneR
November 21st 2019, 8:11am
lonondon @lonondon
RT @BertrandBio: $CLLS $ALCLS A. Choulika stressing again the progress made over the last couple of years with Cell4Cure and MolMed on man…
November 21st 2019, 5:11am
BertrandBio @BertrandBio
$CLLS $ALCLS A. Choulika stressing again the progress made over the last couple of years with Cell4Cure and MolMed… https://t.co/h2JYF0CzAI
November 21st 2019, 5:11am
JacobPlieth @JacobPlieth
Some pretty significant manufacturing investments at $CLLS #Jefferies19 https://t.co/U1SEUBOVQt
November 21st 2019, 5:11am

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2019. All rights reserved.